{"altmetric_id":730124,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["Biotech_Updates"],"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:36620679"],"posts_count":1}},"selected_quotes":["MedWorm- Biotech: Preliminary Thoughts on Mayo v. Prometheus: The Implications for Biotechnology"],"citation":{"altmetric_jid":"4f6fa5913cf058f610004eae","authors":["By Christopher M. Holman"],"doi":"10.1089\/blr.2012.9923","endpage":"113","first_seen_on":"2012-05-06T05:01:23+00:00","issns":["0730-031X","1557-8704"],"issue":"2","journal":"Biotechnology Law Report","last_mentioned_on":1368296520,"links":["http:\/\/online.liebertpub.com\/doi\/abs\/10.1089\/blr.2012.9923","http:\/\/dx.doi.org\/10.1089\/blr.2012.9923"],"pubdate":"2012-04-01T00:00:00+00:00","publisher_subjects":[{"name":"Law","scheme":"era"}],"scopus_subjects":["Life Sciences","Environmental Science","Physical Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"111","title":"\n              Preliminary Thoughts on\n              Mayo v. Prometheus\n              : The Implications for Biotechnology\n            ","type":"article","volume":"31","mendeley_url":"http:\/\/www.mendeley.com\/research\/preliminary-thoughts-mayo-v-prometheus-implications-biotechnology"},"altmetric_score":{"score":3.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3.5},"context_for_score":{"all":{"total_number_of_other_articles":4504824,"mean":5.0923717479595,"rank":913918,"this_scored_higher_than_pct":79,"this_scored_higher_than":3576630,"rank_type":"exact","sample_size":4504824,"percentile":79},"similar_age_3m":{"total_number_of_other_articles":76025,"mean":4.4263921393244,"rank":14097,"this_scored_higher_than_pct":81,"this_scored_higher_than":61624,"rank_type":"exact","sample_size":76025,"percentile":81},"this_journal":{"total_number_of_other_articles":31,"mean":2.1518666666667,"rank":5,"this_scored_higher_than_pct":83,"this_scored_higher_than":26,"rank_type":"exact","sample_size":31,"percentile":83},"similar_age_this_journal_3m":{"total_number_of_other_articles":4,"mean":1.0833333333333,"rank":1,"this_scored_higher_than_pct":75,"this_scored_higher_than":3,"rank_type":"exact","sample_size":4,"percentile":75}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Ph. D. Student":1},"by_discipline":{"Social Sciences":1}}},"geo":{"twitter":{"GB":1},"mendeley":{"BE":1}}},"posts":{"wikipedia":[{"title":"Mayo Collaborative Services v. Prometheus Laboratories, Inc.","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=554623179#altmetric_citation_1","license":"public","citation_ids":[730124],"posted_on":"2013-05-11T18:22:00+00:00","summary":"Mayo v. Prometheus, 566 U.S. ___ (2012), was a case decided by the Supreme Court of the United States that unanimously held that claims directed to a method of giving a drug to a patient, measuring metabolites of that drug, and with a known threshold for e","page_url":"http:\/\/en.wikipedia.org\/?curid=36620679","wiki_lang":"en","author":{"name":"Bender235","url":"http:\/\/en.wikipedia.org\/wiki\/User:Bender235"}}],"twitter":[{"url":"http:\/\/twitter.com\/#!\/Biotech_Updates\/status\/198998327713472513","citation_ids":[730124],"posted_on":"2012-05-06T04:51:13+00:00","author":{"name":"Luke Scicluna","url":"https:\/\/uk.linkedin.com\/in\/lukescicluna","image":"https:\/\/pbs.twimg.com\/profile_images\/577834212562108416\/B95956KH_normal.png","description":"Immunologist\/Neuroscientist who moved to the Biotechnology sector, interested in Life Science developments.","id_on_source":"Biotech_Updates","tweeter_id":"19384782","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":6175},"tweet_id":"198998327713472513"}]}}